Characterization of SVEP1, KIAA, and SRPX2 in an in vitro cell culture model of endotoxemia

Cellular Immunology

Volumn 263, Issue 1, 2010, Pages 65-70

  Schwanzer Pfeiffer, Dagmar ^a   Roßmanith, Eva ^a   Schildberger, Anita ^a   Falkenhagen, Dieter ^a  

^a DANUBE UNIVERSITY KREMS   (Austria)

Author keywords

Complement control protein; Complement system; Endothelial dysfunction; Inflammation; Sepsis

Indexed keywords

CD31 ANTIGEN; COMPLEMENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KIAA0247; PROTEIN SRPX2; PROTEIN SVEP1; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTOXEMIA; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; UNINDEXED SEQUENCE; UPREGULATION;

CELL ADHESION MOLECULES; CELL LINE; COMPLEMENT SYSTEM PROTEINS; CULTURE MEDIA, CONDITIONED; CYTOKINES; ENDOTHELIAL CELLS; ENDOTOXEMIA; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; L-SELECTIN; LIPOPOLYSACCHARIDES; MICROARRAY ANALYSIS; MONOCYTES; NERVE TISSUE PROTEINS; RNA, SMALL INTERFERING;

EID: 77952551332     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.02.017     Document Type: Article

References (22)

1. Opal S.M., Huber C.E. Bench-to-bedside review: toll-like receptors and their role in septic shock. Crit. Care Med. 2002, 6:125-136.
2. Cohen J. The immunopathogenesis of sepsis. Nature 2002, 420:885-891.
3. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 2003, 348:138-150.
4. Suzuki T., Hashimoto S., Toyoda N., Nagai S., Yamazaki N., Dong H.Y., Sakai J., Yamashita T., Nukiwa T., Matsushima K. Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE. Blood 2000, 96:2584-2591.
5. Wang Z.M., Liu C., Dziarski R. Chemokines are the main proinflammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan, and endotoxin. J. Biol. Chem. 2000, 275:20260-20267.
6. Zhao B., Bowden R., Stavchansky S.A., Bowman P.D. Human endothelial cell response to Gram-negative lipopolysaccharide assessed with cDNA microarrays. Am. J. Physiol. Cell Physiol. 2001, 281:C1587-C1595.
7. Haeney M.R. The role of the complement cascade in sepsis. J. Antimicrob. Chemother. 1998, 41:41-46.
8. Huber-Lang M.S., Younkin E.M., Sarma J.V., McGuire S.R., Lu K.T., Guo R.F., Padgaonkar A., Curnutte J.T., Erickson R., Ward P.A. Complement-induced impairment of innate immunity during sepsis. J. Immunol. 2002, 169:3223-3231.
9. Norman D.G., Barlow P.N., Baron M., Day A.J., Sim R.B., Campbell I.D. Three-dimensional structure of a complement control protein module in solution. J. Mol. Biol. 1991, 219:717-725.
10. Chou K.C., Heinrikson R.L. Prediction of the tertiary structure of the complement control module. J. Protein Chem. 1997, 16:765-773.
11. Ichinose A., Bottenus R.E., Davie E.W. Structure of transglutaminases. J. Biol. Chem. 1990, 265:13411-13414.
12. Davie E.W., Ichinose A., Leytus S.P. Structural features of the proteins participating in blood coagulation and fibrinolysis. Cold Spring Harb. Symp. Quant. Biol. 1986, 51:509-514.
13. Kato H., Enjyoji K. Amino acid sequence and location of the disulfide bonds in bovine 2 glycoprotein I: the presence of five Sushi domains. Biochemistry 1999, 30:11687-11694.
14. Bottenus R.E., Ichinose A., Davie E.W. Nucleotide sequence of the gene for the subunit of human factor XIII. Biochemistry 1990, 29:11195-11209.
15. Müller-Eberhard H.J. Molecular organization and function of the complement system. Annu. Rev. Biochem. 1988, 57:321-347.
16. Schildberger A., Rossmanith E., Weber V., Falkenhagen D. Monitoring of endothelial cell activation in experimental sepsis with a two-step cell culture model. Innate Immun. 2009, 1-10.
17. Shur I., Zemer-Tov E., Socher R., Benayahu D. SVEP1 expression is regulated in estrogen-dependent manner. J. Cell. Physiol. 2007, 210:732-739.
18. Kansas G.S. Selectins and their ligands: current concepts and controversies. Blood 1996, 88:3259-3287.
19. Gilges D., Vinit M.A., Callebaut I., Coulombel L., Cacheux V., Romeo P.H., Vigon I. Polydom: a secreted protein with pentraxin, complement control protein, epidermal growth factor and von Willebrand factor A domains. Biochem. J. 2000, 352:49-59.
20. Shur I., Socher R., Hameiri M., Fried A., Benayahu D. Molecular and cellular characterization of SEL-OB/SVEP1 in osteogenic cells in vivo and in vitro. J. Cell. Physiol. 2006, 206:420-427.
21. Harrington E.O., Stefanec T., Newton J., Rounds S. Release of soluble E-selectin from activated endothelial cells upon apoptosis. Lung 2006, 184:259-266.
22. Carr M.W., Roth S.J., Luther E.D., Rose S.S., Springer T.A. Monocyte chemoattractant protein 1 acts as T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. USA 1994, 91:3652-3656.